Brincidofovir FDA Approval Status
FDA Approved: No
Generic name: brincidofovir
Company: Chimerix, Inc.
Treatment for: Smallpox
Brincidofovir is a nucleotide analog broad-spectrum antiviral in development as a medical countermeasure for smallpox.
Development Timeline for brincidofovir
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.